Pharmanutra SpA
MIL:PHN
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
39.15
63.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IT |
|
Pharmanutra SpA
MIL:PHN
|
608.1m EUR |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
203B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
116.6B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.7T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
32.4B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
41.5B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
21.3B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
2.8T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.3T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
909.5B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -79 476% |
| 30th Percentile | 3.9% |
| Median | 8.7% |
| 70th Percentile | 14.4% |
| Max | 813.7% |
Other Profitability Ratios
Pharmanutra SpA
Glance View
Pharmanutra SpA develops nutraceutical products and medical devices. The company is headquartered in Pisa, Pisa. The company went IPO on 2017-07-18. The firm develops nutraceutical products and medical devices. The company focuses on studying and producing formulations that are backed up in scientific research. The company is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The firm offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Pharmanutra SpA is 21.8%, which is below its 3-year median of 24%.
Over the last 3 years, Pharmanutra SpA’s Operating Margin has decreased from 27.9% to 21.8%. During this period, it reached a low of 21.8% on Oct 30, 2025 and a high of 28% on Mar 31, 2023.